🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Fischer Medical Ventures Limited FISCHER NSEPHARMA

Healthcare · Medical Devices · India
https://www.fischermv.com
Company Profile ↓
₹38.10
-50.89% 1Y
Mkt Cap₹2,493.70 Cr
P/B6.43
Div. Yield0.01%
52W High₹117.71
52W Low₹31.21
Book Value₹5.87
EPS (TTM)₹0.02

Company Overview

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 28361.6% per year over the last five years.

Steady Revenue Expansion

Revenue has grown at a 1097.9% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.28.

Recent Developments

  • Mar 2026 Revenue of ₹308.58 Cr (+178.8% YoY); net profit ₹31.02 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +178.8%, earnings +2468.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 1097.9%, profit CAGR 28361.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:1,097.93%
1 Year:178.75%

Compounded Profit Growth

5 Years:28,361.55%
1 Year:2,468.04%

Stock Price Performance

1 Year:-50.89%
6 Months:-5.22%
3 Months:-6.25%
1 Month:+6.54%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed
52-Week Range 8% of range
₹31.21 ₹117.71
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMABelow
  • RSI (14)53.41 · Neutral
Price Performance
1M+6.54%
3M-6.25%
6M-5.22%
1Y-50.89%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 1097.9% over 5 years.
  • Profit CAGR of 28361.6% over 5 years.

CONS

  • Trading 67.6% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-
Industry PE
39.97
Forward P/E
-
PEG Ratio
-
Book Value
₹5.87
Price to Book
6.43
P/S
8.12
EV/EBITDA
62.73
Dividend Yield
0.01%

Growth (CAGR)

Revenue 5Y
1,097.93%
Profit 5Y
28,361.55%
Revenue (YoY)
178.75%
Earnings (YoY)
2,468.04%

Profitability & Returns

ROCE
12.64%
ROE
8.07%
ROA
4.62%
Profit Margin
10.05%
Op Margin
13.00%
Gross Margin
36.62%
EPS (Latest Qtr)
₹-0.11
EPS (TTM)
₹0.02

Balance Sheet & Liquidity

Debt/Equity
0.28
Quick Ratio
1.57
Current Ratio
1.62
Debt
₹107.08 Cr
Total Assets
₹671.01 Cr
Current Assets
₹417.59 Cr
Working Capital
₹159.56 Cr

Ownership

Promoter Holding
76.03%
Chg in Prom Hold
-1.30%
FII / Inst Holding
2.55%
Chg in FII Hold
-3.80%

Financial Snapshot

Enterprise Value
₹2,493.70 Cr
Total Revenue (TTM)
₹308.58 Cr
EBITDA
₹55.18 Cr
Free Cash Flow
₹-102.58 Cr
Operating Cash Flow
₹-101.27 Cr
Shares Outstanding
₹65.45 Cr
Gross Margin
36.62%
Payout Ratio
1.11%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 FISCHER Fischer Medical Ventures Limited NSEPHARMA 38.10 - ₹2,493.70 Cr 0.01% 12.64% 8.07% 1,097.93% 28,361.55%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 020.79 Cr10.12 Cr39.66 Cr11.75 Cr49.17 Cr23.44 Cr86.31 Cr101.10 Cr97.73 Cr
Cost of Revenue ----7.54 Cr39.31 Cr12.76 Cr-50.17 Cr71.03 Cr
Gross Profit ----4.21 Cr9.86 Cr10.68 Cr-50.93 Cr26.70 Cr
Operating Expenses 018.28 Cr10.33 Cr39.16 Cr4.27 Cr7.87 Cr7.19 Cr70.09 Cr30.13 Cr26.63 Cr
Operating Income 02.33 Cr-49.00 L21.00 L-6.11 L1.99 Cr3.49 Cr15.71 Cr20.79 Cr7.73 L
EBITDA 02.51 Cr-21.00 L50.00 L74.84 L2.55 Cr11.61 Cr16.22 Cr22.60 Cr2.27 Cr
Interest Expense 05.00 L13.00 L5.00 L6.69 L22.63 L66.99 L92.00 L63.71 L3.61 Cr
Pretax Income 02.75 Cr7.00 L21.00 L12.44 L1.81 Cr10.18 Cr17.27 Cr21.19 Cr-2.26 Cr
Tax Provision -17.00 L19.00 L-8.00 L41.83 L50.00 L5.17 Cr3.36 Cr1.95 Cr4.86 Cr
Net Income 02.59 Cr-12.00 L29.00 L-29.39 L1.31 Cr5.01 Cr13.90 Cr19.23 Cr-7.12 Cr
Diluted EPS 0.000.05-0.000.01-0.010.010.010.210.29-0.11

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -17.95 L20.98 Cr110.70 Cr308.58 Cr
Cost of Revenue -016.45 Cr91.59 Cr195.59 Cr
Gross Profit -17.95 L4.53 Cr19.11 Cr112.99 Cr
Operating Expenses -16.42 L2.85 Cr17.43 Cr72.88 Cr
Operating Income -1.53 L1.68 Cr1.68 Cr40.10 Cr
EBITDA -1.52 L2.36 Cr4.32 Cr55.18 Cr
Interest Expense -1.65 L6.76 L46.68 L5.83 Cr
Pretax Income --13,0002.11 Cr2.22 Cr46.36 Cr
Tax Provision -3.52 L27.33 L1.01 Cr15.34 Cr
Net Income --3.65 L1.84 Cr1.21 Cr31.02 Cr
Diluted EPS -1.35-0.210.110.02-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -35.35 L86.32 Cr457.37 Cr671.01 Cr
Current Assets -24.79 L70.41 Cr365.29 Cr417.59 Cr
Cash & Equivalents -3.58 L94.83 L104.26 Cr11.89 Cr
Inventory -04.48 Cr9.16 Cr12.66 Cr
Receivables -17.06 L22.87 Cr76.07 Cr288.80 Cr
Total Liabilities -61.95 L5.21 Cr119.50 Cr285.87 Cr
Current Liabilities -4.78 L3.83 Cr101.82 Cr258.03 Cr
Long Term Debt -57.17 L026.25 L26.09 L
Total Debt -57.17 L1.68 Cr85.37 Cr107.08 Cr
Total Equity --26.60 L81.11 Cr337.52 Cr384.39 Cr
Shares Outstanding -17.20 L5.35 Cr63.80 Cr65.45 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow --14.59 L-7.35 Cr-86.25 Cr-101.27 Cr
Investing Cash Flow -0-31.39 Cr-125.36 Cr-5.22 Cr
Financing Cash Flow -16.60 L37.06 Cr314.92 Cr14.11 Cr
Capital Expenditure ---48.49 L-5.99 Cr-1.31 Cr
Free Cash Flow --14.59 L-7.84 Cr-92.24 Cr-102.58 Cr
Net Change in Cash -2.01 L-1.68 Cr103.31 Cr-92.37 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -100.0%21.6%17.3%36.6%
Operating Margin % -8.5%8.0%1.5%13.0%
Net Margin % --20.3%8.8%1.1%10.1%
ROE % -13.7%2.3%0.4%8.1%
ROCE % -5.0%2.0%0.5%9.7%

Shareholding Pattern

Insiders
76.03%
Institutions
2.55%
Public Float
10.62%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for FISCHER

Google News ue, 30 Jun 2026

Idt CFO Marcelo Fischer sells $1.3m in company stock - Investing.com

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxORmJidnU0bVl2aFE5RVFiYVVvQW9rdmtJc2JrTWxIQmdtS0VPcG83UlMzeUNiRDE5YThoeVlWaG5lTmtSQmN6VURJSEt2cTBPVW5oc3ppd2NVdjZDc18xd0szTXJKY1hyLUpNc3BYNThjNFNxMnJ5Y3NuNThEdVJ0Z1hjNFFYZk1JbU80dU…

Google News ue, 07 Jul 2026

Swiss Market Index Recovers; Givaudan, Georg Fischer Shares Up - marketscreener.com

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPb1FkYkU4WUVaTUVfeUt4YUpqVVZpUy0xQW1tMWl5eE9pM2ZVVENfMmxBWHc4dFRyS2R2aWhhZlhqRngzV2NkaFphdm45RWMweksyQXVkcG4xeGlxM3I1M3o4ekpfWllwVjdOTHY5NWtRazFubEh3eVF6Uzl5b2NCZTBvYzQ1VE1tVGFwNG…

Google News hu, 02 Jul 2026

Trade Alert: Chief Financial Officer Of IDT Marcelo Fischer Has Sold Stock - Moomoo

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQLUEwVE9mRDdSRFlIeUNhOWpsLU5UNHlaZ3RsdWJfa1FNY2ltTXR2SEF0S1pjbHFQQU0tV0N5UUluRFk5VnZDamc4aE5fR3hCMkxMOVVKbnI0UU9uMzZ2b242SHppczdJaVdFaFNvb0Joa0Z2eGFKeVNNNDRSdHczNnowOFpucjFnWWYxcE…

Google News Mon, 13 Jul 2026

Georg Fischer stock holds steady as industrial demand shapes long term outlook - Ad-hoc-news.de

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQUnpETmZRUTdWQjNwZmpLRlVWcWFrT0VoazJ0V0ZmelJyUmhJQV8zWjZmMXNyRDIzVHlfMTVCOGh1RW00X3hwU2xURF9Ib1FQTVBlVGxyYkgwSzJHT3UzOG1FcWlEdlBScW1PaFBubGh6emVBdHhiRnZoa1lLbGp3SUdwQkpKUG4xeVM5RW…

Google News Mon, 22 Jun 2026

AEON Biopharma (AEON) director awarded 222,684 RSUs in equity grant - Stock Titan

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNS1cxV2Q4elBFek9qWm51YzNzR0IzbHg4Wm8xRmVLSnpVOGl3UTNxVENENXZKWXBsWnpJZGk4YWo2My1nUXdkRlFjUUt3WlNSRXhuX1BQdUF4NUdNakRsQWFSYXpGdWRoSC1RUmtjTDFQMXhDS2RkUEsxVVFFMG1CN0ZsLWkxSDRpU2dUMz…

Google News Fri, 17 Apr 2026

A Look At Navitas Semiconductor (NVTS) Valuation As Gregory M. Fischer Joins The Board - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQOEdaVDhsRmgtMHRIRmwxZWRWdEc1cjJ4TEZZNTM4dWpGS1Y1enNpQXFSSUdMVG9RcVVvWVBvbFZvT2VIT0dzSUotbG9rVUh1WjF1dzE5OFlYMlRvbHUwTVZUS25GNFdNNk5YbDFUcmlpdXBmMi1BQUE2djhSa2tQZ3EwSnRsV0FvTUlRMl…

FISCHER — Frequently Asked Questions

What is the current share price of Fischer Medical Ventures Limited (FISCHER)?

As of 2026-07-15 09:52 IST, Fischer Medical Ventures Limited (FISCHER) trades at ₹38.10 on NSE. Its 52-week range is ₹31.21 to ₹117.71.

What is the market capitalisation of FISCHER?

Fischer Medical Ventures Limited (FISCHER) has a market capitalisation of ₹2,493.70 Cr on NSE.

Does FISCHER pay a dividend?

Fischer Medical Ventures Limited (FISCHER) currently offers a dividend yield of 0.01%.

What is the return on equity (ROE) of FISCHER?

FISCHER has a return on equity (ROE) of 8.07%. Its return on capital employed (ROCE) is 12.64%.

Is FISCHER a good stock to buy?

This page provides a data-driven analysis of Fischer Medical Ventures Limited (FISCHER), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space